Carl Zeiss Meditec Presents New Precision Technologies and Practice Solutions at the American Academy of Opthalmology Annual Meeting

New solution offerings and partnership to address ophthalmologists’ growing workflow and productivity challenges

ORLANDO/American Academy of Ophthalmology Annual Meeting, October 22, 2011 - Carl Zeiss Meditec will showcase new clinical and productivity tools across the glaucoma, retina, cataract and refractive workplaces during this week’s American Academy of Ophthalmology Annual Meeting in Orlando at booth #821. As part of its complete approach to ophthalmic care, the company will also introduce a partnership with Dr. Jack Holladay, creator of the Holladay 2 formula.

“With an increasing number of patients with serious eye diseases and declining reimbursement, ophthalmologists are faced with more challenges than ever. We know it is no longer enough to just deliver state-of-the-art clinical instruments,” said Dr. Ludwin Monz, President and CEO of Carl Zeiss Meditec AG. “Rather it is important to connect all instruments to a connectivity solution to enable efficiency and continuous workflows. Further crucial elements are training and support so that our customers are able to deliver excellent continuum of care while streamlining their practice and ultimately increasing their revenue.”

At AAO, Carl Zeiss Meditec will demonstrate the new FORUM® LINK Tools for their eye care data management system, which offer greater connectivity by allowing data integration of non-DICOM-compliant instruments with the benefits of a DICOM workflow. FORUM uses HL7 and DICOM communication standards to create a closed-loop information flow of patient demographics to the company’s and DICOM-enabled third-party instruments. It also integrates data with a wide variety of electronic health records (EHRs), including NextGenTM Healthcare, Compulink, Epic, Greenway® Medical, ifa® systems and VersaSuite. FORUM, together with an EHR system, combines image and practice management software for a complete, centralized, paperless record of diagnostic images, patient history and demographics.

FORUM will also be exhibited at the AAO sponsored IHE Eye Care Multi-vendor Interoperability Showcase at the Electronic Office booth #3345.

Carl Zeiss Meditec continuously works on enhancing the clinical benefits of its systems. The company’s partnership with Dr. Jack Holladay will enable the company to incorporate the 4th generation Holladay 2 formula inside its IOLMaster® 500, the standard-of-care for precision biometry. Currently, the Holladay 2 formula enables a faster, easier and more convenient approach to obtain highly accurate intraocular lens (IOL) power calculations and is the leading formula used by U.S. cataract surgeons. Exclusive to Carl Zeiss Meditec, the IOLMaster 500 will be the only biometer on the market with the Holladay 2 formula inside the instrument, enabling surgeons to do calculations without the need to transfer data to an external computer.

“I am gratified that a much larger population of surgeons and their patients will benefit from the improved accuracy of IOL power calculations by having direct access to the Holladay 2 formula,” said Dr. Holladay.

Additionally, Carl Zeiss Meditec’s U.S. Customer Care division, recipient of the North Face Scoreboard Award for service excellence since 2003, is expanding its service offerings to provide customers with more options and flexibility in choosing a plan that best meets their service needs.

“With our comprehensive product offerings and service plans, we are providing our customers with a greater level of benefits to support and enhance their patient care and increase their efficiency in the workplace,” said Dr. Monz. “We strive to provide high precision technology and comprehensive service programs that ensure that we are partnering with our customers for the entire lifespan of their instrument and beyond.”

Brief profile Carl Zeiss Meditec AG Carl Zeiss Meditec AG (ISIN: DE0005313704) is one of the world’s leading medical technology companies. The company supplies innovative technologies and application-oriented solutions which enable doctors to improve the quality of life of their patients. It offers complete solutions, including implants and consumables, to diagnose and treat eye diseases. In the field of microsurgery the company provides innovative visualization solutions. The medical technology portfolio of Carl Zeiss Meditec is rounded off by promising future-oriented technologies such as intraoperative radiotherapy. The Company's around 2,200 employees generated revenues of about EUR 676 million in fiscal year 2009/10 (ended Sept. 30).

Carl Zeiss Meditec is headquartered in Jena, Germany. In addition to other subsidiaries in Germany, the company is represented by over 50 percent of its employees at sites in the USA, Japan, Spain and France. 35 percent of Carl Zeiss Meditec shares are in free float. The remaining 65% are held by Carl Zeiss AG, one of the world’s leading groups in the optical and optoelectronic industry. Carl Zeiss offers innovative solutions for the future-oriented markets of Medical and Research Solutions, Industrial Solutions, Eye Care and Lifestyle Products. During fiscal year 2009/109 the group of companies generated revenues of around EUR 2.98 billion. From fiscal year 2010/11, eyeglass lens manufacturer Carl Zeiss Vision will be integrated as an autonomous business group (revenues of EUR 880 million in fiscal year 2009/10). The Carl Zeiss Group now has approximately 24,000 employees, including more than 10,000 in Germany. Carl Zeiss AG, Oberkochen, is fully owned by the Carl Zeiss Stiftung (Carl Zeiss Foundation).